NIH-funded research R01 grant

Orexin blockers to reduce alcohol craving

Official title: Influence of Orexin Antagonism on Motivation for Alcohol

Funded at University of Kentucky · NIH-11329086 · Data updated 2026-11-12

This project will see whether medicines that block the brain chemical orexin can reduce the urge to drink in people with alcohol use disorder.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startMarch 15, 2024
Project endFebruary 28, 2027
Funding year2026
Award (this year)$511,222
NIH project number5R01AA030775-03
Project IDNIH-11329086 on NIH RePORTER

Who could benefit from this research

Could help

Adults with alcohol use disorder or heavy drinking who are medically stable and willing to attend clinic visits and complete lab behavioral tests are the best match.

Less likely to help

People without alcohol problems, pregnant people, or those taking medications that interact with orexin blockers may not benefit or could be ineligible.

What this research studies

You would receive a medication that blocks orexin, a brain chemical linked to motivation, and researchers will watch how that changes your wanting and effort to get alcohol using lab tasks and questionnaires. They may compare the orexin blocker to a placebo and measure drinking-related choices, craving, and sleep changes after chronic alcohol exposure. The study builds on animal work showing orexin blockers lower alcohol-seeking and aims to translate those findings into people with problematic drinking. Visits will likely include controlled lab sessions and monitoring over weeks to capture behavioral and sleep outcomes.

Why it matters

Potential benefit: If successful, this could lead to a new medicine that lowers craving and helps prevent relapse for people with alcohol use disorder.

How similar studies have gone: Strong animal studies show orexin blockers reduce alcohol-seeking and improve sleep, but clinical evidence in people with AUD is still limited.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Stoops, William Walton — University of Kentucky
  • Study coordinator: Stoops, William Walton

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.